EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access

Clinical Outcomes of Magnetic Seizure Therapy vs Electroconvulsive Therapy for Major Depressive Episode

Zhi-De Deng, Bruce Luber, Shawn M McClintock, Richard D Weiner, Mustafa M Husain, Sarah H Lisanby

JAMA Psychiatry · 01.03.2024 · 81 (3) · 240

DOI: 10.1001/jamapsychiatry.2023.4599 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift JAMA Psychiatry, erschienen am 01.03.2024. Verfasst von Zhi-De Deng und 5 weiteren Autor:innen. Beteiligte Einrichtung: Noninvasive Neuromodulation Unit, Experimental Therapeutics Branch, Intramural Research Program, National Institute of Mental Health, Bethesda, Maryl…. Hauptthemen laut MEDLINE: Major Depressive Disorder, Electroconvulsive Therapy. Die Arbeit wurde bisher 66-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIMH NIH HHS, NCATS NIH HHS, Intramural NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Importance Electroconvulsive therapy (ECT) is highly effective and rapid in treating depression, but it carries a risk of significant cognitive adverse effects. Magnetic seizure therapy (MST), an investigational antidepressant treatment, may maintain the robust antidepressant efficacy of ECT while substantially reducing adverse effects due to its enhanced focality and weaker stimulation strength; however, previous clinical trials of MST were limited by small sample sizes.

Objective

To compare the antidepressant efficacy of MST vs ultrabrief pulse right unilateral (RUL) ECT. Design, Setting, and Participants A between-participants, double-blinded, randomized clinical trial was conducted at 3 academic hospitals from June 2007 to August 2012. Adults aged 18 to 90 years who were referred for treatment with ECT, had a major depressive episode in the context of major depressive disorder or bipolar disorder, and had a baseline 24-item Hamilton Depression Rating Scale (HDRS-24) total score of 18 or higher were included. Participants were randomly assigned 1:1 to treatment with MST or ultrabrief pulse RUL ECT. After the treatment course, patients were naturalistically followed up for up to 6 months to examine the durability of clinical effects.

Interventions

Treatment with MST, applied at 100 Hz at 100% of the maximum device power for 10 seconds, or ultrabrief pulse RUL ECT, applied at 6 times seizure threshold. Main Outcomes and Measures The primary outcome was change from baseline in HDRS-24 total score, with patients followed up for up to 6 months. A reduction of at least 50% in the HDRS-24 score indicated response, and at least a 60% decrease in the HDRS-24 score and a total score of 8 or less indicated remission.

Results

Of the 73 participants (41 [56.2%] female; mean [SD] age, 48 [14.1] years), 35 were randomized to MST and 38 to ECT. Among them, 53 (72.6%) were classified as completers (29 in the MST group and 24 in the ECT group). Both MST and ECT demonstrated clinically meaningful antidepressant effects. In the intent-to-treat sample, 18 participants (51.4%) in the MST group and 16 (42.1%) in the ECT group met response criteria; 13 (37.1%) in the MST group and 10 (26.3%) in the ECT group met remission criteria. Among completers, 17 of 29 (58.6%) in the MST group and 15 of 24 (62.5%) in the ECT group met response criteria; 13 of 29 (44.8%) in the MST group and 10 of 24 (41.7%) in the ECT group met remission criteria. There was no significant difference between MST and ECT for either response or remission rates. However, the mean (SD) number of treatments needed to achieve remission was 9.0 (3.1) with MST and 6.7 (3.3) with ECT, a difference of 2.3 treatments ( t 71.0 = 3.1; P = .003). Both MST and ECT showed a sustained benefit over a 6-month follow-up period, again with no significant difference between them. Compared with MST, ECT had significantly longer time to orientation after treatment (threshold level: F 1,56 = 10.0; P = .003) and greater severity of subjective adverse effects, particularly in the physical and cognitive domains. Conclusions and Relevance This randomized clinical trial found that the efficacy of MST was indistinguishable from that of ultrabrief pulse RUL ECT, the safest form of ECT currently available. These results support the continued development of MST and provide evidence for advantages relative to state-of-the-art ECT. Trial Registration ClinicalTrials.gov Identifier: NCT00488748

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Major Depressive DisorderElectroconvulsive TherapyAdultHumansFemaleMiddle AgedMaleTreatment OutcomeAntidepressive AgentsSeizures

Substanzen

Antidepressive Agents

Autor:innen und Institutionen

  • Noninvasive Neuromodulation Unit, Experimental Therapeutics Branch, Intramural Research Program, National Institute of Mental Health, Bethesda, Maryland.
  • Department of Psychiatry and Behavioral Sciences, Duke University School of Medicine, Durham, North Carolina.
  • Department of Psychiatry, University of Texas Southwestern Medical Center, Dallas.

Förderung

  • NIMH NIH HHS
  • NCATS NIH HHS
  • Intramural NIH HHS

Zitieren

APA

Deng, Z. D., Luber, B., McClintock, S. M., Weiner, R. D., Husain, M. M., & Lisanby, S. H. (2024). Clinical Outcomes of Magnetic Seizure Therapy vs Electroconvulsive Therapy for Major Depressive Episode. JAMA Psychiatry, 81(3), 240. https://doi.org/10.1001/jamapsychiatry.2023.4599

Vancouver

Deng ZD, Luber B, McClintock SM, Weiner RD, Husain MM, Lisanby SH. Clinical Outcomes of Magnetic Seizure Therapy vs Electroconvulsive Therapy for Major Depressive Episode. JAMA Psychiatry. 2024;81(3):240. doi:10.1001/jamapsychiatry.2023.4599

BibTeX
@article{Deng2024,
  author = {Deng, Zhi-De and Luber, Bruce and McClintock, Shawn M and Weiner, Richard D and Husain, Mustafa M and Lisanby, Sarah H},
  title = {Clinical Outcomes of Magnetic Seizure Therapy vs Electroconvulsive Therapy for Major Depressive Episode},
  journal = {JAMA Psychiatry},
  year = {2024},
  volume = {81},
  number = {3},
  pages = {240},
  doi = {10.1001/jamapsychiatry.2023.4599}
}
Kostenlos starten →